The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK), First California Financial Group, Inc. (FCAL), Metropolitan Health Networks, Inc. (MDF) and DUSA Pharmaceuticals Inc. (DUSA)

Friday, November 09, 2012

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK), First California Financial Group, Inc. (FCAL), Metropolitan Health Networks, Inc. (MDF) and DUSA Pharmaceuticals Inc. (DUSA)11:34 EST Friday, November 09, 2012NEW YORK, Nov. 9, 2012 /PRNewswire/ --Kayak Software CorporationLevi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share. Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972. (Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)First California Financial Group, Inc.Levi & Korsinsky is investigating the Board of Directors of First California Financial Group, Inc. (Nasdaq: FCAL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PacWest Bancorp (Nasdaq: PACW) for stock valued at approximately $8 per share. Click here to learn more about the investigation: http://zlk.9nl.com/first-california-financial-fcal, or call: 877-363-5972.Metropolitan Health Networks, Inc.Levi & Korsinsky is investigating the Board of Directors of Metropolitan Health Networks, Inc. (NYSE: MDF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Humana Inc. (NYSE: HUM) for $11.25 per share. At least one analyst set a price target for Metropolitan stock at $13.00 per share.Click here to learn more about the investigation: http://zlk.9nl.com/metropolitan-health-networks-mdf, or call: 877-363-5972. DUSA Pharmaceuticals Inc.Levi & Korsinsky is investigating the Board of Directors of DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.Click here to learn more about the investigation: http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky, Esq.30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500Toll Free:  (877) 363-5972Fax: (212) 363-7171www.zlk.comSOURCE Levi & Korsinsky, LLP